erythromycin has been researched along with scopolamine hydrobromide in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (22.22) | 18.2507 |
2000's | 3 (33.33) | 29.6817 |
2010's | 4 (44.44) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Du-Cuny, L; Mash, EA; Meuillet, EJ; Moses, S; Powis, G; Song, Z; Zhang, S | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Mims, ME; Stewart, JJ; Wood, CD; Wood, MJ | 1 |
Hyman, PE; Itoh, Z; Koneko, H; Mansy, HA; Masahiko, T; Morikawa, A; Sandler, RH; Tomomasa, T | 1 |
Shimada, M; Tanen, DA; Young, C | 1 |
1 review(s) available for erythromycin and scopolamine hydrobromide
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
8 other study(ies) available for erythromycin and scopolamine hydrobromide
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain.
Topics: Antineoplastic Agents; Blood Proteins; Caco-2 Cells; Cell Membrane Permeability; Computer Simulation; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Phosphoproteins; Protein Binding; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-akt; Quantitative Structure-Activity Relationship | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Effects of motion sickness and antimotion sickness drugs on gastric function.
Topics: Adolescent; Adult; Electromyography; Erythromycin; Female; Gastric Emptying; Humans; Male; Motion Sickness; Promethazine; Rotation; Scopolamine; Stomach | 1994 |
Gastrointestinal sounds and migrating motor complex in fasted humans.
Topics: Adult; Auscultation; Breath Tests; Digestive System Physiological Phenomena; Erythromycin; Fasting; Gastrointestinal Transit; Humans; Male; Manometry; Metoclopramide; Myoelectric Complex, Migrating; Scopolamine; Somatostatin; Sound | 1999 |
Corneal ulcer associated with pepper spray exposure during military training.
Topics: Adult; Anti-Bacterial Agents; Corneal Ulcer; Erythromycin; Humans; Irritants; Law Enforcement; Male; Military Personnel; Mydriatics; Occupational Exposure; Ophthalmic Solutions; Plant Extracts; Scopolamine; United States; Young Adult | 2012 |